New Insights into Down Syndrome Brain Development

Scientists from Duke-NUS Medical School, in collaboration with Imperial College London and partners in Europe and the United States, have identified new insights into how an additional copy of chromosome 21 alters brain development in Down syndrome.

The study, published in Nature Medicine, found that three key genes on chromosome 21 act as master regulators of brain-related genetic activity.

These three genes were observed to be overactive in human brain cells derived from individuals with Down syndrome, leading to disruptions in the normal activity of hundreds of other genes involved in learning and memory. These widespread changes may explain how an extra chromosome influences brain function.

Potential for Modulation

The research team explored whether these effects could be modulated using antisense oligonucleotides (ASOs), which are synthetic strands of genetic material designed to reduce the activity of specific genes.

When the activity of the three overactive genes was reduced in laboratory-grown human brain cells, a partial restoration of more typical gene activity patterns was observed.

This early-stage laboratory work provides proof of concept that some molecular changes associated with Down syndrome may be biologically adjustable, offering a new framework for understanding the condition. Dr. Michael Lattke stated that the study demonstrates how combining advanced technologies can reveal new biological insights.

Future Implications

Down syndrome is also the most common genetic cause of Alzheimer's disease. By clarifying how chromosome 21 disrupts gene regulation in brain cells, these findings may inform future studies into shared biological pathways between these conditions, though researchers stress that clinical applications remain a long-term goal.

Professor Vincenzo De Paola acknowledged the contributions of families to this research.

Professor Lok Sheemei noted that the study provides a new framework for understanding Down syndrome at the cellular level, identifying specific genes, pathways, and cell populations that may drive neurological changes and offer potential targets for future therapies.

The research team is currently focused on understanding the functional consequences of adjusting these key drivers, including whether normalizing their activity can influence how brain cells grow and form connections.

A patent related to their methods has been filed, and advanced human neural models are being used to test whether targeting specific combinations of genes may be necessary to influence brain cell function.